Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Olivia C. Ware | Director | 2024-04-16 | 9,402 | $7.61 | $71.55kBuy |
Olivia C. Ware | Director | 2024-04-16 | 6,790 | $55.36 | $375.91kSell |
Olivia C. Ware | Director | 2024-04-16 | 2,612 | $56.03 | $146.35kSell |
Rami Elghandour | President CEO and Chairman of the Board | 2024-04-01 | 14,919 | $66.67 | $994.68kSell |
Rami Elghandour | President CEO and Chairman of the Board | 2024-04-01 | 5,456 | $67.58 | $368.73kSell |
Rami Elghandour | President CEO and Chairman of the Board | 2024-04-01 | 2,711 | $68.42 | $185.48kSell |
Christopher Heery | CHIEF MEDICAL OFFICER | 2024-03-26 | 861 | $70.19 | $60.43kSell |
Christopher Heery | CHIEF MEDICAL OFFICER | 2024-03-26 | 5,450 | $6.28 | $34.23kBuy |
Christopher Heery | CHIEF MEDICAL OFFICER | 2024-03-26 | 2,555 | $68.55 | $175.14kSell |
Christopher Heery | CHIEF MEDICAL OFFICER | 2024-03-26 | 2,034 | $69.36 | $141.08kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Gilead Sciences Inc | 12.73% | 6,720,803 | $348.94M | Insider |
Sr One Capital Management LLC | 12.35% | 6,520,370 | $338.54M | Insider |
Jill Carroll | 12.01% | 6,340,738 | $329.21M | Insider |
Scott D. Sandell | 8.99% | 4,748,116 | $246.52M | Insider |
Peter W. Sonsini | 8.99% | 4,746,083 | $246.42M | Insider |
Mohamad Makhzoumi | 8.99% | 4,745,545 | $246.39M | Insider |
Forest Baskett | 8.99% | 4,745,262 | $246.37M | Insider |
Anthony A. Florence Jr. | 8.99% | 4,745,262 | $246.37M | Insider |
New Enterprise Associates 15 LP | 8.99% | 4,745,262 | $246.37M | Insider |
Nea Partners 15 LP | 8.99% | 4,745,262 | $246.37M | Insider |